Elcelyx Therapeutics Gets $1.2M

San Diego-based Elecelyx Therapeutics, a stealth mode biotech firm, has raised $1.2M in a funding round, which includes Morgenthaler Ventures, according to a regulatory filing this week. Details on the funding have not been announced by the company. The filing indicates the firm is looking to raised $2.2M in the round. Elecelyx Therapeutics is headed by Alain Baron, former Senior Vice President, Research, Amylin Pharmaceuticals, and now an EIR at Morgenthaler. Morgenthaler's Ralph Christofferson also holds a board seat. More information »